GWM
IBDN

Geneos Wealth Management’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Geneos Wealth Management’s Portfolio IBDN Stock Details IBDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,061
Closed -$76K – 2135
2022
Q3 		$76K Sell
3,061
-1,050
-26% -$26.3K 0.01% 885
2022
Q2 		$102K Hold
4,111
– – 0.01% 1000
2022
Q1 		$102K Sell
4,111
-100
-2% -$2.51K ﹤0.01% 1087
2021
Q4 		$105K Sell
4,211
-250
-6% -$6.3K ﹤0.01% 1149
2021
Q3 		$112K Buy
4,461
+1,511
+51% +$38.3K ﹤0.01% 1129
2021
Q2 		$74K Sell
2,950
-4,061
-58% -$103K ﹤0.01% 1302
2021
Q1 		$178K Hold
7,011
– – 0.01% 1022
2020
Q4 		$75K Buy
7,011
+3,911
+126% +$100K ﹤0.01% 1264
2020
Q3 		$79K Buy
3,100
+1,500
+94% +$38.5K ﹤0.01% 1049
2020
Q2 		$41K Hold
1,600
– – ﹤0.01% 1304
2020
Q1 		$39K Hold
1,600
– – ﹤0.01% 1226
2019
Q4 		$40K Hold
1,600
– – ﹤0.01% 1379
2019
Q3 		$40K Sell
1,600
-1,585
-50% -$40K ﹤0.01% 1300
2019
Q2 		$80K Hold
3,185
– – 0.01% 992
2019
Q1 		$79K Buy
3,185
+595
+23% +$14.6K 0.01% 950
2018
Q4 		$62K Hold
2,590
– – ﹤0.01% 1004
2018
Q3 		$63K Buy
2,590
+990
+62% +$24.1K ﹤0.01% 1065
2018
Q2 		$38K Sell
1,600
-990
-38% -$24.1K ﹤0.01% 1182
2018
Q1 		$63K Buy
2,590
+1,600
+162% +$39.4K 0.01% 915
2017
Q4 		$24K Hold
990
– – ﹤0.01% 1318
2017
Q3 		$25K Hold
990
– – ﹤0.01% 1248
2017
Q2 		$24K Hold
990
– – ﹤0.01% 1215
2017
Q1 		$24K Hold
990
– – ﹤0.01% 1184
2016
Q4 		$24K Hold
990
– – ﹤0.01% 1119
2016
Q3 		$25K Hold
990
– – ﹤0.01% 1058
2016
Q2 		$25K Buy
+990
New +$24.9K ﹤0.01% 1048

Other funds holding IBDN

OIA
Optimum Investment Advisors Chicago, Illinois $252M AUM 26.44% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Geneos Wealth Management's IBDN Position: Q4 2022 in Review

Geneos Wealth Management sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q4 2022, closing a stake of 3,061 shares — an estimated $76K sold.

Geneos Wealth Management first reported a position in IBDN in Q2 2016 and held it in 26 quarters. The position peaked at $178K in Q1 2021. 2 funds tracked by Wall St. Rank hold IBDN as of Q4 2022.

  • Geneos Wealth Management reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q4 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 3,061 iShares iBonds Dec 2022 Term Corporate ETF shares in Q4 2022, an estimated $76K.
  • Geneos Wealth Management first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q2 2016 and held it in 26 quarters.
  • Geneos Wealth Management's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $178K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q4 2022.

Based on Geneos Wealth Management's 13F filing for Q4 2022, filed 31 Jan 2023.